Skip to content

Ingrid Delaet, Chief Regulatory Officer at Neurocrine Biosciences, sold NBIX on Jul 9, 2026

Data as of Oct 16

▼ SELL$1.5M8,433 shares at $178.72Ingrid Delaet Chief Regulatory OfficerNBIX Neurocrine Biosciences Inc
Watch NBIX
Traded
Jul 9, 2026
Disclosed
Jul 9, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Ingrid Delaet, Chief Regulatory Officer at Neurocrine Biosciences, sold NBIX on Jul 9, 2026TRADEDDISCLOSED
NBIXSimilar stocks (XLV — its sector index fund), rebased to NBIX's price on the disclosure day
NBIX since disclosure
−24.8%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund

Change in closing price from Jul 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLIngrid Delaet Chief Regulatory OfficerNBIX Neurocrine Biosciences Inc$489Kdisclosed Jul 9 · filed 1 day after the trade
  2. ▼ SELLIngrid Delaet Chief Regulatory OfficerNBIX Neurocrine Biosciences Inc$607Kdisclosed Jul 9 · filed 2 days after the trade

See every trade on NBIX →